BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22623708)

  • 1. Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort.
    Fagherazzi G; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1171-5. PubMed ID: 22623708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
    Ritte R; Lukanova A; Tjønneland A; Olsen A; Overvad K; Mesrine S; Fagherazzi G; Dossus L; Teucher B; Steindorf K; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita B; van Duijnhoven F; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Krum-Hansen S; Gram IT; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; McCormack V; Riboli E; Kaaks R
    Int J Cancer; 2013 Jun; 132(11):2619-29. PubMed ID: 23090881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
    Manders P; Pijpe A; Hooning MJ; Kluijt I; Vasen HF; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer H; Ausems MG; van Os TA; Gomez-Garcia EB; Brohet RM; ; van Leeuwen FE; Rookus MA
    Breast Cancer Res Treat; 2011 Feb; 126(1):193-202. PubMed ID: 20730487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
    Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.
    Fagherazzi G; Guillas G; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Eur J Cancer Prev; 2013 Jan; 22(1):29-37. PubMed ID: 22694827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmö Diet and Cancer cohort.
    Wirfält E; Li C; Manjer J; Ericson U; Sonestedt E; Borgquist S; Landberg G; Olsson H; Gullberg B
    Nutr Cancer; 2011; 63(5):722-33. PubMed ID: 21767080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of birthweight and the incidence of breast cancer in adulthood.
    Michels KB; Xue F; Terry KL; Willett WC
    Carcinogenesis; 2006 Dec; 27(12):2464-8. PubMed ID: 16777984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of age at menarche with adult leg length and trunk height: Speculations in relation to breast cancer risk.
    Osuch JR; Karmaus W; Hoekman P; Mudd L; Zhang J; Haan P; Mikucki D
    Ann Hum Biol; 2010; 37(1):76-85. PubMed ID: 19968595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort.
    Fagherazzi G; Fabre A; Boutron-Ruault MC; Clavel-Chapelon F
    Eur J Cancer Prev; 2010 Mar; 19(2):120-5. PubMed ID: 20042864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.